14-day Premium Trial Subscription Try For FreeTry Free
$53.09
+0.150 (+0.283%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $50.35 $57.15 Thursday, 2nd May 2024 INCY stock ended at $53.09. This is 0.283% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.26% from a day low at $52.28 to a day high of $53.46.
90 days $50.35 $61.87
52 weeks $50.27 $67.72

Historical Incyte Corporation prices

Date Open High Low Close Volume
Dec 07, 2023 $55.66 $55.66 $54.70 $55.18 1 209 328
Dec 06, 2023 $54.71 $55.64 $54.25 $55.42 1 289 116
Dec 05, 2023 $54.69 $55.42 $54.52 $54.82 1 405 079
Dec 04, 2023 $55.28 $55.94 $54.68 $54.96 1 842 321
Dec 01, 2023 $54.42 $54.61 $53.62 $54.02 1 762 179
Nov 30, 2023 $53.93 $54.52 $53.63 $54.34 3 832 345
Nov 29, 2023 $52.92 $53.66 $52.80 $53.39 1 448 861
Nov 28, 2023 $52.92 $52.92 $52.20 $52.70 1 724 016
Nov 27, 2023 $53.64 $53.68 $52.41 $52.87 1 169 373
Nov 24, 2023 $53.58 $53.78 $53.21 $53.74 425 784
Nov 22, 2023 $53.53 $54.10 $53.24 $53.40 1 079 403
Nov 21, 2023 $53.20 $54.00 $52.82 $53.23 1 455 556
Nov 20, 2023 $54.49 $55.18 $54.21 $54.71 1 434 692
Nov 17, 2023 $54.46 $54.49 $53.78 $54.27 2 859 014
Nov 16, 2023 $55.13 $55.17 $53.55 $53.99 1 647 443
Nov 15, 2023 $54.44 $55.50 $54.31 $54.98 1 910 536
Nov 14, 2023 $53.60 $54.81 $53.38 $54.57 1 826 859
Nov 13, 2023 $52.09 $53.41 $52.09 $53.12 1 557 177
Nov 10, 2023 $52.73 $52.73 $51.47 $52.44 1 506 137
Nov 09, 2023 $54.25 $54.25 $52.32 $52.52 1 547 096
Nov 08, 2023 $54.85 $54.85 $53.48 $54.06 1 680 522
Nov 07, 2023 $54.36 $54.92 $54.05 $54.72 1 076 130
Nov 06, 2023 $55.20 $55.36 $54.35 $54.57 1 180 351
Nov 03, 2023 $54.25 $55.00 $54.02 $54.85 1 962 287
Nov 02, 2023 $54.22 $54.75 $53.51 $53.97 1 293 820
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT